• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内脑膜瘤切除术术中失血的风险因素:530 例分析。

Risk factors for intraoperative blood loss in resection of intracranial meningioma: Analysis of 530 cases.

机构信息

Department of Anesthesiology, Sichuan Provincial People' Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.

出版信息

PLoS One. 2023 Sep 8;18(9):e0291171. doi: 10.1371/journal.pone.0291171. eCollection 2023.

DOI:10.1371/journal.pone.0291171
PMID:37682850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10490957/
Abstract

PURPOSE

Excision of intracranial meningioma has been associated with major intraoperative blood loss (IBL). The objective of the study was to identify factors affecting IBL during removal of meningioma.

METHODS

We retrospectively studied medical records of 530 adult patients who underwent surgery for intracranial meningioma at Sichuan Provincial People's Hospital between September 2018 and May 2022. We obtained the following data from each patient's medical chart: age, sex, height, weight, comorbidities, blood pressure, history of smoking and alcohol, imaging examination findings, pathologic diagnosis, albumin, creatinine, calcium, magnesium, hemoglobin (Hb), hematocrit, platelet count, activated partial thromboplastin time, international normalized ratio, fibrinogen concentration and blood transfusion. Univariate and multivariate analyses were performed to identify risk factors for greater IBL during removal of intracranial meningioma.

RESULTS

A total of 530 patients were included in our study. Univariate analysis revealed that sex (p = 0.004), two-dimensional (2D) tumor area (p < 0.001), sinus involvement (p = 0.014), World Health Organization grade (p = 0.015), preoperative albumin level (p = 0.032), preoperative Hb level (p = 0.001) and preoperative platelet count (p = 0.004) were significantly associated with greater IBL. Multivariate analysis revealed that greater 2D tumor area (p < 0.001), higher preoperative albumin concentration (p = 0.029) and higher preoperative platelet count (p = 0.03) were independent risk factors for greater IBL in resection of intracranial meningioma.

CONCLUSION

Larger tumor size, higher preoperative albumin concentration and higher preoperative platelet count were identified as independent risk factors for greater IBL in resection of intracranial meningioma.

摘要

目的

切除颅内脑膜瘤与术中大量失血(IBL)有关。本研究的目的是确定影响脑膜瘤切除术中 IBL 的因素。

方法

我们回顾性研究了 2018 年 9 月至 2022 年 5 月在四川省人民医院接受颅内脑膜瘤手术的 530 例成年患者的病历。从每位患者的病历中获取以下数据:年龄、性别、身高、体重、合并症、血压、吸烟和饮酒史、影像学检查结果、病理诊断、白蛋白、肌酐、钙、镁、血红蛋白(Hb)、血细胞比容、血小板计数、活化部分凝血活酶时间、国际标准化比值、纤维蛋白原浓度和输血。进行单因素和多因素分析,以确定颅内脑膜瘤切除术中 IBL 增加的危险因素。

结果

本研究共纳入 530 例患者。单因素分析显示,性别(p = 0.004)、二维(2D)肿瘤面积(p < 0.001)、窦受累(p = 0.014)、世界卫生组织分级(p = 0.015)、术前白蛋白水平(p = 0.032)、术前 Hb 水平(p = 0.001)和术前血小板计数(p = 0.004)与 IBL 增加显著相关。多因素分析显示,2D 肿瘤面积较大(p < 0.001)、术前白蛋白浓度较高(p = 0.029)和术前血小板计数较高(p = 0.03)是颅内脑膜瘤切除术中 IBL 增加的独立危险因素。

结论

较大的肿瘤大小、较高的术前白蛋白浓度和较高的术前血小板计数被确定为颅内脑膜瘤切除术中 IBL 增加的独立危险因素。

相似文献

1
Risk factors for intraoperative blood loss in resection of intracranial meningioma: Analysis of 530 cases.颅内脑膜瘤切除术术中失血的风险因素:530 例分析。
PLoS One. 2023 Sep 8;18(9):e0291171. doi: 10.1371/journal.pone.0291171. eCollection 2023.
2
Extent of T1+C Intensity Is a Predictor of Blood Loss in Resection of Meningioma.T1加权增强(T1+C)强化程度是脑膜瘤切除术出血量的一个预测指标。
World Neurosurg. 2017 May;101:69-75. doi: 10.1016/j.wneu.2017.01.098. Epub 2017 Feb 4.
3
Analysis of risk factors affecting wound healing and wound infection after meningioma resection.分析影响脑膜瘤切除术后伤口愈合和感染的危险因素。
Int Wound J. 2024 Apr;21(4):e14870. doi: 10.1111/iwj.14870.
4
Correlation between preoperative imaging features and intraoperative blood loss of meningioma: a new scoring system for predicting intraoperative blood loss.脑膜瘤术前影像学特征与术中出血量的相关性:一种预测术中出血量的新评分系统。
J Neurosurg Sci. 2013 Jun;57(2):153-61.
5
Evaluation of acute normovolemic hemodilution in patients undergoing intracranial meningioma resection: A quasi-experimental trial.颅内脑膜瘤切除术患者急性等容性血液稀释的评估:一项准实验性试验。
Medicine (Baltimore). 2017 Sep;96(38):e8093. doi: 10.1097/MD.0000000000008093.
6
Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.复发性颅内脑膜瘤再行放射外科治疗的结果分析
Clin Neurol Neurosurg. 2017 Feb;153:93-101. doi: 10.1016/j.clineuro.2016.12.014. Epub 2016 Dec 29.
7
Surgical Management of Giant Intracranial Meningioma: Operative Nuances, Challenges, and Outcome.巨大颅内脑膜瘤的外科治疗:手术细节、挑战与结果
World Neurosurg. 2018 Feb;110:e32-e41. doi: 10.1016/j.wneu.2017.09.184. Epub 2017 Oct 5.
8
Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.56例颅内和脊髓内透明细胞型脑膜瘤的临床特征、治疗及预后因素
World Neurosurg. 2018 Mar;111:e880-e887. doi: 10.1016/j.wneu.2017.12.173. Epub 2018 Jan 8.
9
Intracranial meningioma surgery in the elderly (over 65 years): prognostic factors and outcome.老年(65岁以上)颅内脑膜瘤手术:预后因素与结果
Acta Neurochir (Wien). 2015 Sep;157(9):1549-57; discussion 1557. doi: 10.1007/s00701-015-2502-9. Epub 2015 Jul 14.
10
Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study.颅内脑膜瘤手术中癫痫发作的长期控制及预测因素:一项基于人群的研究。
Acta Neurochir (Wien). 2018 Mar;160(3):589-596. doi: 10.1007/s00701-017-3434-3. Epub 2018 Jan 11.

引用本文的文献

1
Cerebral flow estimated from 3D pCASL for prediction of intraoperative blood loss in non-embolized meningiomas: a feasibility study.通过三维伪连续动脉自旋标记技术估计脑血流以预测非栓塞性脑膜瘤术中失血量:一项可行性研究。
Quant Imaging Med Surg. 2025 Apr 1;15(4):3308-3321. doi: 10.21037/qims-24-2326. Epub 2025 Mar 28.
2
Intraoperative tranexamic acid administration in cranial meningioma surgery: a meta-analysis of prospective randomized, double-blinded, and placebo-controlled trials.颅脑膜瘤手术中术中使用氨甲环酸:前瞻性随机、双盲和安慰剂对照试验的荟萃分析
Front Oncol. 2024 Aug 29;14:1464671. doi: 10.3389/fonc.2024.1464671. eCollection 2024.
3
Risk factor analysis and establishment of a nomogram model to predict blood loss during total knee arthroplasty.风险因素分析及建立全膝关节置换术失血量预测列线图模型。
BMC Musculoskelet Disord. 2024 Jun 10;25(1):459. doi: 10.1186/s12891-024-07570-3.
4
Scalp necrosis following preoperative endovascular embolisation of the superficial temporal artery for meningioma.头皮坏死,术前对脑膜瘤进行的颞浅动脉血管内栓塞。
BMJ Case Rep. 2024 Apr 8;17(4):e257848. doi: 10.1136/bcr-2023-257848.

本文引用的文献

1
Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.颅内巨大脑膜瘤切除术术前栓塞的临床结局与并发症:一项回顾性、观察性、匹配队列研究
Front Oncol. 2022 Mar 8;12:852327. doi: 10.3389/fonc.2022.852327. eCollection 2022.
2
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy.在表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂(TKI)治疗失败后,EGFR突变的晚期非小细胞肺癌患者中,化疗联合抗血管生成疗法与化疗联合免疫疗法的真实世界疗效。
Transl Lung Cancer Res. 2021 Sep;10(9):3782-3792. doi: 10.21037/tlcr-21-681.
3
Clinical Outcome and Risk Factors of Red Blood Cell Transfusion in Patients Undergoing Elective Primary Meningioma Resection.择期原发性脑膜瘤切除术患者红细胞输血的临床结局及危险因素
Cancers (Basel). 2021 Jul 18;13(14):3601. doi: 10.3390/cancers13143601.
4
Intraoperative tranexamic acid use in patients undergoing excision of intracranial meningioma: Randomized, placebo-controlled trial.颅内脑膜瘤切除术患者术中使用氨甲环酸:随机、安慰剂对照试验。
Surg Neurol Int. 2021 Jun 14;12:289. doi: 10.25259/SNI_177_2021. eCollection 2021.
5
Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: A prospective randomized, double-blind, placebo-controlled study.氨甲环酸对颅内脑膜瘤切除术失血、凝血指标及手术视野质量的影响:一项前瞻性随机双盲安慰剂对照研究
Surg Neurol Int. 2021 Jun 7;12:272. doi: 10.25259/SNI_296_2021. eCollection 2021.
6
Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume.2型糖尿病中的血小板黏附:血浆白蛋白和平均血小板体积的影响
Thromb J. 2021 Jun 2;19(1):40. doi: 10.1186/s12959-021-00291-w.
7
Platelet-Mediated Protection of Cancer Cells From Immune Surveillance - Possible Implications for Cancer Immunotherapy.血小板介导的癌细胞免疫逃避及其对癌症免疫治疗的启示
Front Immunol. 2021 Mar 10;12:640578. doi: 10.3389/fimmu.2021.640578. eCollection 2021.
8
Investigating Effective Factors on Estimated Hemorrhage Intraoperative in Brain Meningioma Surgery.探究脑膜瘤手术中估计术中出血量的影响因素。
Basic Clin Neurosci. 2020 Sep-Oct;11(5):631-638. doi: 10.32598/bcn.9.10.370. Epub 2020 Sep 1.
9
Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study.术前栓塞与非栓塞治疗 WHO Ⅰ级颅内脑膜瘤:一项回顾性匹配队列研究。
J Neurosurg. 2020 Mar 27;134(3):693-700. doi: 10.3171/2020.1.JNS19788. Print 2021 Mar 1.
10
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.依维莫司与奥曲肽治疗复发性脑膜瘤患者:CEVOREM Ⅱ期试验结果。
Clin Cancer Res. 2020 Feb 1;26(3):552-557. doi: 10.1158/1078-0432.CCR-19-2109. Epub 2020 Jan 22.